{"ticker": {"uuid": "c4fbc4f4-a7ca-40d5-9101-040232216c54", "symbol": "2269", "name": "WuXi Biologics (Cayman) Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Wuxi Biologics (Cayman) Stock Advances 2.4% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQYllrSm9GRUdicGpfN2NXVk9Qd2RKOC1iZTFvczFCQUkxbUxtclJOdExURVFWZGFlUmtONU4yYU5OUHkxSm9VcjRXSGtDVFYycTdZSzhRNGptMUQzNHJ0dG13TFR1cWVfS1BvSTNkMlhtUy16N2hfeHhWQkxrZ2lmVkw1TW1YUGNPYm5SVFZGOExvS0NyX2JfVzIyaw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T14:09:50+00:00", "published_display": "14 Jul 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein initiates Wuxi Biologics stock coverage at Market Perform By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNUkIyczZYQXM2Vmx3TG9tR3UzY05pZUMxY3JKN3ZfbmhHaG80cTVrVzZQaVViajZrZHlsb2xvSlBzSFlrVkZKaC1xRnIwc3JaaXB1WEVLdUtYem1oRkJZZEc3Y2t3R3NXRnNERE9QRjdwTjl4RHNlT1ZuakxsWC1iVlA4QzNqWDJOd3hGVEtyZ3MzZkh2Zm41dFFLaFZvT0NhTlpKdG5LUVVoN2FmZmRLbHI5bUhCVHlMSUExLWNoQnJJRjF4OVRZ?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T13:23:18+00:00", "published_display": "14 Jul 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (Cayman) (SEHK:2269) Wins FDA Inspection As Its Undervalued Case Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOZzNJM1IweC1QWUpmc0VOM1U2eTRJU3FfN0c5bXM3UEhIdlFsbHQxdlZyT04xSzh3dVZfY192S05qQzNPWXhfR1BEcWpmLU5fXzhPUGFOZ3Z1ektDbUxSTWM1OEFLa2FHNlZnQWYtd2Nkak1BNlJVOFR6Z2dXUllCQXJLZ0dGY2hVX0M4U2hNLUVGY0t0blUyeUZLOUMwUkVnczlTckNmTGEtLUlwVWlCdVJ3X0JLa0hQY1Rva2U2Q1dZZ0hybXNrbllXcnRxeXlJTWZreTNuV2xiQ2ZlOUROOG1FQmNCR01mWlozbWl2QmbSAfYBQVVfeXFMUFJESS1HUTNOMGVJc1JFNnJvUDRjWG16QUVaSXpLbHljNGI1M01rdDJhUldmZUZ3emVla1VRS21SUGhuMThNd0pVenVLQzlkc1lXd1owNGVDb05UWVBIM25zcGxqUWZILXY1MWhhQU5wb2FjVkhFYmNzaTBXbHNYcFQ2bEtlMUNaZEkwSXVxSmdsY3c4dXE4dUY1WFU3QkFCSEJWTVFSZmJuNmZyM2NaTFJVUzg5cDJlS0VEckg2cGRwQnR4bzhLamFwRFd1NlRrYmg3dGpxd2o5ZWF6V0xpRHdCSEtQOEY3Qk1GQ0ZycEQxS2pBSURn?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T19:25:57+00:00", "published_display": "11 Jul 2026 19:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wuxi Biologics (Cayman) Stock Rallies 3.9% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZVB5UzRqSDdsMUtKZ3hBSWpGMzlRdXdrT0FqY2dyeWtNNEpMSi1CRmZNZm5UN3NUWXpVVG9hRUNLR3ViYld1dnFONTdHYkFJWGh0eTFfS1RLTFRVaHBoN3JOMDhITE1VOGlXXy05YWo5V3F1NGpHXzJZRjhxS0xrb0pkY3d1RERURDM4NGF0UjFVZGg0UUNMWE1R?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T10:14:11+00:00", "published_display": "09 Jul 2026 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing WuXi Biologics (SEHK:2269) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUW82VGZ3bWxnTEJUWC12T0NDbkR5T1ByNzZCdFN5Q2VPSlFvXzNIT3JMM2dBX0VtaXZZbkJncTFxZEQtZ3NPM2Z2X0Q1NGpsN0VNZHl0M0stZ2RENFZjMHE2VmtSOTFwUjRHcUZyZHlIc2c1RUhjc2Nkb1kyWVUxZ01pQjh1UjFuU0dGbWM0M2EtOGdyTmlGMG9GVjJTZDEw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Chengdu Milestone Raises Questions On Capacity Use And Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxNcDBLTm5WV2dOMUd4ZlRKUDNGQWhkTWZKeWsxYm1NQndNLVZXOGtCU3lPc3VxWnZsdzFla2tZSlNqMlNRd3J3eExUVVVfcnJsUTVJUjM2Tk01YkxPZHB2MERGRzRKcU16aC16LUpTWVl1LVlqaURwNDJLSmMzOC1RMHRlU3Q0THM4SmkzSDlkSDRNRW1FTnVHOW95aTMxNWRLRi1scFRBQkN2cEJPSVBNTXFYODZmMWRwdElNZlotZEV3NDQ3STMtVDNmWnRYTk9tVHo0X3NvZzc3eE9TUGZMNFBfU0FicU1YZXMtVUgwQ2rSAfYBQVVfeXFMUC1OaVFxYm83VGlVTzBCVGFxT0s3RnNZS3dXN2dXWGxDUDlJMjlHUmUxSGZ5YjJSSEhSM0R5dGRCUW9VeEhTSjctbFhDYVZTdzRkVjVtR1AwTXY5czczUkVjc2c4RmwxMG1sTFE5WUkzR3NRVk5tNkVTWjYweUxSb3VOWUdET1k5eVVGS2JPc2RzOE5KeVlaR19aVzZ6QmpqOGIxekRZQjFEY25OY2U3bTNGVmpPbld1VW5aU0gwUnFBbGk2d1NJMmZvRDVYRURBZC1obk9kV0Q0TGFORTFGdVRNSFNUTjJkLUUxSEtFdFNZTkFrSmR3?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics' major shareholder to offload nearly $5.8 billion shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOa2ZSakNrUWlJVnk4RUlVYzNZTlZna3lWcnRMN3JRbzZrZEp2ZnZyOTExMUNGUkJ5N05tNk1ZZ3QtU0Jpd0pyMG1KWTJaZ1hzc2dmTnZETC1GUkdPQ3RyNTdmbm4tR3RVZDJOSmNRdTV1QmJHMTlnRW9rbmFtaDA2Rk0tUnNfZHVzMi1IQWduMEttMVltaE9XZWhfX3NWMmRWLWlkVy1kT2ZKaDdlS09IVWZaZGo2UGlIcVhhdEZMcw?oc=5", "source_name": "thestandard.com.hk", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Ireland records \u20ac98 million loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQQnQxUi1LRURKRXZtV1NTUEh4SlpWZzlxeGJXVGxncmRRZWMxSFJBM2hKZG1xM09nN3NEQ3EyRzFNZkRVZ1FKdTU5aTB6VHJOZjFpN1E1OUVZWVhEWmJhZjRLRG03VTdEWWNHdnJOUlg5Z21vaXFmTTYyWUlqRlVJQkhrRXZvUXdfMFdOYjVqUQ?oc=5", "source_name": "Business Post", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Reports Solid 2024 Interim Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9EMzI5LW1PaTZiUFFsTjRDd0tiUjh1eFlGb3NJaEU3N2hjRFpqMmQzSWVGcUZlNG5RLUxSMTh6Y2daNUw5MVVLNVpmbE5BeE1vYlVCWWo3ei1CWS1wZHdCcm93LVQyeFRBWTI0aw?oc=5", "source_name": "\ud31c\ub274\uc2a4", "published_at": "2024-08-22T07:00:00+00:00", "published_display": "22 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over US biotech bill", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPODhwNE4yWUFzRjlfUVlrVFhFZW0xcFBaMDRLMEhmM29wbUdod0Z5d3VHb1ZEQk16MzBUNkV5UFVyYzlULVpwTnRFM2NBRzhBeVBNcnExSDN5MUtZb1ROTTdxc1ZYY1NORDV4ZEpIME9xQjFpZ08tWmtUVThZT2xYRGFwc21UUlRZZWtRRDBlUHl5SGlldGpMXzNzZEZ6SUhidjNFVk5INkZxM09NbjQtcFJrTS1oaXAzcXUtRmJUWmFnOU8taDVveXoyX1g4Z1hsN0syRnVXREdFU0MyN1p6RzhlM1A?oc=5", "source_name": "Reuters", "published_at": "2024-02-02T08:00:00+00:00", "published_display": "02 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics' medical research unit eyes up to $471 mln in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOZGMwREdQd1dVZTlyT1Q0UnFQOGE0b3dIcHBmOElwZHJhNFE3TnNXS1lOWXVqbFpCUW5jSlhPVXB3SVlEelp5bFNDWnJLVWxhN2Q2LTFlc0RVVmxBdTU1bHlDWlBMaGZPX3NYS1dmeXpheXNaZm54cFQweUtxNXBWTXpIZklQRTZIU3RxbjRGTVRITTFIc0hnaEpWTF9lMDZObnJPWXhZcmZ0N2lqMkpXdUR2WUg5dw?oc=5", "source_name": "Reuters", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (Cayman) Inc. Stock (2269) - Quote Hong Kong S.E.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQS1R6bUZIa2NBc1dYRWRyMmdXaVFHNVBJWkFSbE9yZG1rbHZqWERPSXVfSy1FMHVlZ3VhSzh6dVhwcGZkTkhuRk5NUnJOQnpHU3JldjFXb0t0cF8wSnZBWTBLWllqaXJOa0hfU21iVExQNERQSEdEMXRxWGdmTi1MSXJPYzQ?oc=5", "source_name": "marketscreener.com", "published_at": "2022-03-26T08:12:37+00:00", "published_display": "26 Mar 2022 08:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Wuxi Biologics (Cayman) Inc. (HKEX:2269)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE04MldoZTFmWjR4TElSTXJYTjZ2ckZBaG9WemxDa1JXcTN5eTRlcnkzNVJVY01YdHZpOVpfOFdUczNXdEtudkptMUd6blMyd3QxYlJoN3NHUG1WRWt5OWZEdWpNekxpek9a?oc=5", "source_name": "TradingView", "published_at": "2018-02-04T17:32:33+00:00", "published_display": "04 Feb 2018 17:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Completes IPO and Begins Trading on the Hong Kong Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNk9aLTFSZm95X3pIcFI4N2s4SXVpODNTTjhIM2lOSWl0bHVFcnpCb1pwM0NPRTJ1OWdpZ1hNd2Nub0d1RGx1TkVxc0pWREZrM1lNTXRfekVBNnhVVjN2UTJVN180am5vN0JwbkpvRktqQ2RvTDdVYkhDd1hQbmttWE5SbnBQakxsQkJPc3NIbjhueHZhci1zSlJTYkMxejNPYkZNS2dBWEtiaEl6WEx6dmFzaXBUdjNZ?oc=5", "source_name": "Wilson Sonsini", "published_at": "2017-06-13T07:00:00+00:00", "published_display": "13 Jun 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Wuxi Biologics (Cayman) Stock Advances 2.4% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQYllrSm9GRUdicGpfN2NXVk9Qd2RKOC1iZTFvczFCQUkxbUxtclJOdExURVFWZGFlUmtONU4yYU5OUHkxSm9VcjRXSGtDVFYycTdZSzhRNGptMUQzNHJ0dG13TFR1cWVfS1BvSTNkMlhtUy16N2hfeHhWQkxrZ2lmVkw1TW1YUGNPYm5SVFZGOExvS0NyX2JfVzIyaw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T14:09:50+00:00", "published_display": "14 Jul 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein initiates Wuxi Biologics stock coverage at Market Perform By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNUkIyczZYQXM2Vmx3TG9tR3UzY05pZUMxY3JKN3ZfbmhHaG80cTVrVzZQaVViajZrZHlsb2xvSlBzSFlrVkZKaC1xRnIwc3JaaXB1WEVLdUtYem1oRkJZZEc3Y2t3R3NXRnNERE9QRjdwTjl4RHNlT1ZuakxsWC1iVlA4QzNqWDJOd3hGVEtyZ3MzZkh2Zm41dFFLaFZvT0NhTlpKdG5LUVVoN2FmZmRLbHI5bUhCVHlMSUExLWNoQnJJRjF4OVRZ?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T13:23:18+00:00", "published_display": "14 Jul 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (Cayman) (SEHK:2269) Wins FDA Inspection As Its Undervalued Case Builds", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T19:25:57+00:00", "published_display": "11 Jul 2026 19:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wuxi Biologics (Cayman) Stock Rallies 3.9% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZVB5UzRqSDdsMUtKZ3hBSWpGMzlRdXdrT0FqY2dyeWtNNEpMSi1CRmZNZm5UN3NUWXpVVG9hRUNLR3ViYld1dnFONTdHYkFJWGh0eTFfS1RLTFRVaHBoN3JOMDhITE1VOGlXXy05YWo5V3F1NGpHXzJZRjhxS0xrb0pkY3d1RERURDM4NGF0UjFVZGg0UUNMWE1R?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T10:14:11+00:00", "published_display": "09 Jul 2026 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing WuXi Biologics (SEHK:2269) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUW82VGZ3bWxnTEJUWC12T0NDbkR5T1ByNzZCdFN5Q2VPSlFvXzNIT3JMM2dBX0VtaXZZbkJncTFxZEQtZ3NPM2Z2X0Q1NGpsN0VNZHl0M0stZ2RENFZjMHE2VmtSOTFwUjRHcUZyZHlIc2c1RUhjc2Nkb1kyWVUxZ01pQjh1UjFuU0dGbWM0M2EtOGdyTmlGMG9GVjJTZDEw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Chengdu Milestone Raises Questions On Capacity Use And Returns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics' major shareholder to offload nearly $5.8 billion shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOa2ZSakNrUWlJVnk4RUlVYzNZTlZna3lWcnRMN3JRbzZrZEp2ZnZyOTExMUNGUkJ5N05tNk1ZZ3QtU0Jpd0pyMG1KWTJaZ1hzc2dmTnZETC1GUkdPQ3RyNTdmbm4tR3RVZDJOSmNRdTV1QmJHMTlnRW9rbmFtaDA2Rk0tUnNfZHVzMi1IQWduMEttMVltaE9XZWhfX3NWMmRWLWlkVy1kT2ZKaDdlS09IVWZaZGo2UGlIcVhhdEZMcw?oc=5", "source_name": "thestandard.com.hk", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Ireland records \u20ac98 million loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQQnQxUi1LRURKRXZtV1NTUEh4SlpWZzlxeGJXVGxncmRRZWMxSFJBM2hKZG1xM09nN3NEQ3EyRzFNZkRVZ1FKdTU5aTB6VHJOZjFpN1E1OUVZWVhEWmJhZjRLRG03VTdEWWNHdnJOUlg5Z21vaXFmTTYyWUlqRlVJQkhrRXZvUXdfMFdOYjVqUQ?oc=5", "source_name": "Business Post", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Reports Solid 2024 Interim Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9EMzI5LW1PaTZiUFFsTjRDd0tiUjh1eFlGb3NJaEU3N2hjRFpqMmQzSWVGcUZlNG5RLUxSMTh6Y2daNUw5MVVLNVpmbE5BeE1vYlVCWWo3ei1CWS1wZHdCcm93LVQyeFRBWTI0aw?oc=5", "source_name": "\ud31c\ub274\uc2a4", "published_at": "2024-08-22T07:00:00+00:00", "published_display": "22 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over US biotech bill", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPODhwNE4yWUFzRjlfUVlrVFhFZW0xcFBaMDRLMEhmM29wbUdod0Z5d3VHb1ZEQk16MzBUNkV5UFVyYzlULVpwTnRFM2NBRzhBeVBNcnExSDN5MUtZb1ROTTdxc1ZYY1NORDV4ZEpIME9xQjFpZ08tWmtUVThZT2xYRGFwc21UUlRZZWtRRDBlUHl5SGlldGpMXzNzZEZ6SUhidjNFVk5INkZxM09NbjQtcFJrTS1oaXAzcXUtRmJUWmFnOU8taDVveXoyX1g4Z1hsN0syRnVXREdFU0MyN1p6RzhlM1A?oc=5", "source_name": "Reuters", "published_at": "2024-02-02T08:00:00+00:00", "published_display": "02 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics' medical research unit eyes up to $471 mln in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOZGMwREdQd1dVZTlyT1Q0UnFQOGE0b3dIcHBmOElwZHJhNFE3TnNXS1lOWXVqbFpCUW5jSlhPVXB3SVlEelp5bFNDWnJLVWxhN2Q2LTFlc0RVVmxBdTU1bHlDWlBMaGZPX3NYS1dmeXpheXNaZm54cFQweUtxNXBWTXpIZklQRTZIU3RxbjRGTVRITTFIc0hnaEpWTF9lMDZObnJPWXhZcmZ0N2lqMkpXdUR2WUg5dw?oc=5", "source_name": "Reuters", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics (Cayman) Inc. Stock (2269) - Quote Hong Kong S.E.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQS1R6bUZIa2NBc1dYRWRyMmdXaVFHNVBJWkFSbE9yZG1rbHZqWERPSXVfSy1FMHVlZ3VhSzh6dVhwcGZkTkhuRk5NUnJOQnpHU3JldjFXb0t0cF8wSnZBWTBLWllqaXJOa0hfU21iVExQNERQSEdEMXRxWGdmTi1MSXJPYzQ?oc=5", "source_name": "marketscreener.com", "published_at": "2022-03-26T08:12:37+00:00", "published_display": "26 Mar 2022 08:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Wuxi Biologics (Cayman) Inc. (HKEX:2269)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE04MldoZTFmWjR4TElSTXJYTjZ2ckZBaG9WemxDa1JXcTN5eTRlcnkzNVJVY01YdHZpOVpfOFdUczNXdEtudkptMUd6blMyd3QxYlJoN3NHUG1WRWt5OWZEdWpNekxpek9a?oc=5", "source_name": "TradingView", "published_at": "2018-02-04T17:32:33+00:00", "published_display": "04 Feb 2018 17:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "WuXi Biologics Completes IPO and Begins Trading on the Hong Kong Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNk9aLTFSZm95X3pIcFI4N2s4SXVpODNTTjhIM2lOSWl0bHVFcnpCb1pwM0NPRTJ1OWdpZ1hNd2Nub0d1RGx1TkVxc0pWREZrM1lNTXRfekVBNnhVVjN2UTJVN180am5vN0JwbkpvRktqQ2RvTDdVYkhDd1hQbmttWE5SbnBQakxsQkJPc3NIbjhueHZhci1zSlJTYkMxejNPYkZNS2dBWEtiaEl6WEx6dmFzaXBUdjNZ?oc=5", "source_name": "Wilson Sonsini", "published_at": "2017-06-13T07:00:00+00:00", "published_display": "13 Jun 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 15, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 13, "score": 50, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 7.85, "count": 13}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 37.96, "latest_week": "2026-07-10", "one_week_move": 1.1, "four_week_move": 22.1, "twelve_week_move": 6.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.216776, "market_dynamics_buy_signal": false, "relative_strength": 16.040364, "fair_value_gap": 39.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.8313, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.1% over one week, +22.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 3}, {"label": "Moomoo", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "Investing.com South Africa", "count": 1}, {"label": "Market source", "count": 1}, {"label": "thestandard.com.hk", "count": 1}, {"label": "Business Post", "count": 1}, {"label": "\ud31c\ub274\uc2a4", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Regulatory and legal", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.1% over one week, +22.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Wuxi Biologics (Cayman) Stock Advances 2.4% in Hong Kong"}], "updated_at": "2026-07-17T11:42:35.881973+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}